Thursday, April 17, 2014 7:08:33 PM
http://news.yahoo.com/bank-america-reports-276-mn-loss-huge-legal-115604732.html
New York (AFP) - Bank of America reported Wednesday a quarterly loss of $276 million due to $6 billion in legal expenses that included a huge settlement with the US on mortgage-backed securities.
Related Stories
Bank of America reports loss on huge legal charges AFP
Bank of America posts loss, hurt by legal expenses Associated Press
Bank of America shares fall on Q1 earnings loss MarketWatch
Recap of Bank of America call: Moynihan hopes for 'relief' from mounting legal bills MarketWatch
Bank of America: the good, the bad and the ugly MarketWatch
The bank had revenues of $22.8 billion, compared with earnings of $1.5 billion on revenues of $23.4 billion in the period a year ago. Operating results were mixed and included weaker mortgage banking profits but higher investment and brokerage income.
"The cost of resolving more of our mortgage issues hurt our earnings this quarter," said chief executive Brian Moynihan.
"But the earnings power of our business and customer strategy generated solid results and we continued to return excess capital to our shareholders."
The US banking giant said $3.6 billion of the legal costs were associated with a $9.5 billion settlement with the Federal Housing Finance Agency to resolve charges that it sold bad mortgage-backed securities to mortgage giants Freddie Mac and Fannie Mae ahead of the housing bust.
The additional legal costs also went mostly to address other mortgage-related problems, the bank said.
Results in BofA's consumer real estate services division were hit by declines in mortgage refinancings, mirroring an industry-wide trend.
But on the positive side, BofA benefited from improving credit quality. It set aside $1 billion in provisions for credit losses, down from $1.7 billion a year ago.
The bank also reported higher profits for its global markets segment.
Bank of America shares were off 0.7 percent in pre-market trade to $16.27.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM